WOCKPHARMA2024-04-012024-06-30 WOCKPHARMA2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2024-04-012024-06-30in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2024-06-30 WOCKPHARMA2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532300 WOCKPHARMA NA Wockhardt Limited Equity 2024-04-01 2025-03-31 2024-08-09 2024-08-05 INR Crores First quarter 12:20:00 14:50:00 2024-08-09 2024-08-09 Not applicable Single segment Pharmaceuticals 2024-04-01 2024-06-30 Unaudited Standalone 3520000000.00 270000000.00 3790000000.00 820000000.00 310000000.00 140000000.00 620000000.00 580000000.00 430000000.00 830000000.00 3730000000.00 60000000.00 0.00 60000000.00 0.00 0.00 0.00 0.00 60000000.00 0.00 0.00 0.00 0.00 60000000.00 0.00 60000000.00 0.00 0.00 770000000.00 5 0.39 0.39 0.00 0.00 0.39 0.39 1)The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 09, 2024. The results have been subjected to limited review by the Statutory Auditors of the Company. 2)Figures for the quarter ended March 31, 2024 is the balancing figure between the audited figures of the full financial year and the reviewed figures upto the third quarter of financial year 2023-24. 3)The Company is exclusively into Pharmaceutical business Segment. Exchange fluctuation loss, net 10000000.00 other expenses 820000000.00 Items that will not be reclassified to Profit or Loss - (charge)/credit (consisting of re-measurement of net defined benefit (liability)/asset) 0.00 Income tax relating to items that will not be reclassified to Profit or Loss 0.00 0.00 0.00 0.00